Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194462 | SCV000248924 | benign | not specified | 2017-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082123 | SCV000288959 | benign | Creatine transporter deficiency | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315504 | SCV000848549 | benign | Inborn genetic diseases | 2016-05-05 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000233099 | SCV001145706 | benign | not provided | 2018-12-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000233099 | SCV001868177 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV001082123 | SCV003920489 | likely benign | Creatine transporter deficiency | 2022-05-18 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF 0.7% (84/10760) including 39 hemizygotes (https://gnomad.broadinstitute.org/variant/X-153695071-C-T?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as Benign (Variation ID:212213). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is an intronic variant with no predicted change in the amino acid sequence but may have an unknown effect on splicing. Computational prediction tools do not suggest that it alters splicing. However, further studies are needed to understand its impact. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign. |
Genome Diagnostics Laboratory, |
RCV000194462 | SCV001927491 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000233099 | SCV001973385 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001828019 | SCV002084580 | likely benign | Creatine deficiency syndrome 1 | 2019-12-20 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003927808 | SCV004739362 | benign | SLC6A8-related disorder | 2019-05-15 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |